Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Long-term quality of life and postthrombotic syndrome in women after an episode of venous thromboembolism.

Ljungqvist M, Holmström M, Kieler H, Lärfars G.

Phlebology. 2018 May;33(4):234-241. doi: 10.1177/0268355517698620. Epub 2017 Mar 16.

PMID:
28956493
2.

High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines.

Eriksen J, Gustafsson LL, Ateva K, Bastholm-Rahmner P, Ovesjö ML, Jirlow M, Juhasz-Haverinen M, Lärfars G, Malmström RE, Wettermark B, Andersén-Karlsson E; Stockholm DTC.

BMJ Open. 2017 May 2;7(4):e014345. doi: 10.1136/bmjopen-2016-014345.

3.

Cardiovascular disease and mortality after a first episode of venous thromboembolism in young and middle-aged women.

Ljungqvist M, Holmström M, Kieler H, Odeberg J, Lärfars G.

Thromb Res. 2016 Feb;138:80-85. doi: 10.1016/j.thromres.2015.11.039. Epub 2015 Dec 2.

PMID:
26826509
4.

F11 is associated with recurrent VTE in women. A prospective cohort study.

Bruzelius M, Ljungqvist M, Bottai M, Bergendal A, Strawbridge RJ, Holmström M, Silveira A, Kieler H, Hamsten A, Lärfars G, Odeberg J.

Thromb Haemost. 2016 Jan;115(2):406-14. doi: 10.1160/TH15-06-0459. Epub 2015 Oct 1.

PMID:
26423325
5.

The importance of the costoclavicular space in upper limb primary deep vein thrombosis, a study with magnetic resonance imaging (MRI) technique enhanced by a blood pool agent.

Arnhjort T, Nordberg J, Delle M, Borgis CJ, Rosfors S, Lärfars G.

Eur J Intern Med. 2014 Jul;25(6):545-9. doi: 10.1016/j.ejim.2014.05.005. Epub 2014 May 27.

PMID:
24873726
6.

Risk factors for recurrent venous thromboembolism in young and middle-aged women.

Ljungqvist M, Sonnevi K, Bergendal A, Holmström M, Kieler H, Lärfars G.

Thromb Res. 2014 May;133(5):762-7. doi: 10.1016/j.thromres.2014.02.017. Epub 2014 Feb 26.

PMID:
24613699
7.

Self-reported family history in estimating the risk of hormone, surgery and cast related VTE in women.

Sonnevi K, Bergendal A, Adami J, Lärfars G, Kieler H.

Thromb Res. 2013 Aug;132(2):164-9. doi: 10.1016/j.thromres.2013.06.003. Epub 2013 Jun 22.

PMID:
23800637
8.

Non-steroidal anti-inflammatory drugs and venous thromboembolism in women.

Bergendal A, Adami J, Bahmanyar S, Hedenmalm K, Lärfars G, Persson I, Sundström A, Kieler H.

Pharmacoepidemiol Drug Saf. 2013 Jun;22(6):658-66.

PMID:
23508885
9.

Obesity and thrombin-generation profiles in women with venous thromboembolism.

Sonnevi K, Tchaikovski SN, Holmström M, Antovic JP, Bremme K, Rosing J, Lärfars G.

Blood Coagul Fibrinolysis. 2013 Jul;24(5):547-53. doi: 10.1097/MBC.0b013e32835f93d5.

PMID:
23470648
10.

Extended use of dabigatran, warfarin, or placebo in venous thromboembolism.

Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, Kvamme AM, Friedman J, Mismetti P, Goldhaber SZ; RE-MEDY Trial Investigators; RE-SONATE Trial Investigators.

N Engl J Med. 2013 Feb 21;368(8):709-18. doi: 10.1056/NEJMoa1113697.

11.

Risk factors for venous thromboembolism in pre-and postmenopausal women.

Bergendal A, Bremme K, Hedenmalm K, Lärfars G, Odeberg J, Persson I, Sundström A, Kieler H.

Thromb Res. 2012 Oct;130(4):596-601. doi: 10.1016/j.thromres.2012.05.024. Epub 2012 Jun 14.

PMID:
22704078
12.

Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.

Sonnevi K, Tchaikovski SN, Holmström M, Rosing J, Bremme K, Lärfars G.

Thromb Haemost. 2011 Nov;106(5):901-7. doi: 10.1160/TH11-04-0254. Epub 2011 Sep 22.

PMID:
21947267
13.

Deep venous thrombosis after surgery for Achilles tendon rupture: a provoked transient event with minor long-term sequelae.

Persson LM, Lapidus LJ, Lärfars G, Rosfors S.

J Thromb Haemost. 2011 Aug;9(8):1493-9. doi: 10.1111/j.1538-7836.2011.04376.x.

14.

Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.

Farahnak P, Lärfars G, Sten-Linder M, Nilsson IL.

J Clin Endocrinol Metab. 2011 Jul;96(7):2112-8. doi: 10.1210/jc.2011-0238. Epub 2011 May 18.

PMID:
21593116
15.

The 'wise list'- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm.

Gustafsson LL, Wettermark B, Godman B, Andersén-Karlsson E, Bergman U, Hasselström J, Hensjö LO, Hjemdahl P, Jägre I, Julander M, Ringertz B, Schmidt D, Sjöberg S, Sjöqvist F, Stiller CO, Törnqvist E, Tryselius R, Vitols S, von Bahr C; Regional Drug Expert Consortium.

Basic Clin Pharmacol Toxicol. 2011 Apr;108(4):224-33. doi: 10.1111/j.1742-7843.2011.00682.x.

16.

Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study.

Höög CM, Broström O, Lindahl TL, Hillarp A, Lärfars G, Sjöqvist U.

BMC Gastroenterol. 2010 Sep 28;10:113. doi: 10.1186/1471-230X-10-113.

17.

A follow-up study of the fate of small asymptomatic deep venous thromboses.

Rosfors S, Persson LM, Lärfars G, Lapidus LJ.

Thromb J. 2010 Feb 12;8:4. doi: 10.1186/1477-9560-8-4.

18.

Forecasting drug utilization and expenditure in a metropolitan health region.

Wettermark B, Persson ME, Wilking N, Kalin M, Korkmaz S, Hjemdahl P, Godman B, Petzold M, Gustafsson LL; Regional Drug Expert Consortium in Stockholm County Council.

BMC Health Serv Res. 2010 May 17;10:128. doi: 10.1186/1472-6963-10-128.

19.

[New drug in atrial fibrillation--how does it function in regular health care?].

Holmström M, Johnsson H, Lärfars G, Malmström R, Hjemdahl P.

Lakartidningen. 2009 Nov 4-12;106(45):3019-20. Swedish. No abstract available.

PMID:
19998831
20.

Dabigatran versus warfarin in the treatment of acute venous thromboembolism.

Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ; RE-COVER Study Group.

N Engl J Med. 2009 Dec 10;361(24):2342-52. doi: 10.1056/NEJMoa0906598.

Supplemental Content

Loading ...
Support Center